Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Individual susceptibility to carcinogens

Abstract

The contribution of polymorphisms in carcinogen metabolizing genes to overall cancer rates may vary widely between groups with differing allele frequencies and with varying levels of carcinogenic exposure. Their effects are modified by interactions with each other and with other genes, particularly those involved in DNA repair. Studies on the combined effects of particular polymorphisms on colorectal and other cancers, and also on intermediate markers such as DNA adduct formation, are discussed. Such susceptibility genes are of considerable scientific interest, but do not confer high enough risks to be clinically relevant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Berwick M, Matullo G and Vineis P . (2002). Biomarkers of Environmentally Associated Disease SH Wilson, WA Suk, (eds). Lewis Publishers: Boca Raton.

    Google Scholar 

  • Berwick M and Vineis P . (2000). J. Natl. Cancer Inst., 92, 874–897.

  • Burnet NG, Johansen J, Turesson I, Nyman J and Peacock JH . (1998). Int. J. Cancer, 79, 606–613.

  • Dybdahl M, Vogel, Frentz G, Wallin H and Nexo BA . (1999). Cancer Epidemiol. Biomark. Prev., 8, 77–81.

  • Eyfjord JE . (2000). Proceedings of the Workshop ‘Molecular Epidemiology: a new tool in cancer prevention’ F Perera, CC Harris, (eds). Keystone Symposia: Taos, February 10–15.

    Google Scholar 

  • Garte S . (1998). Carcinogenesis, 19, 1329–1332.

  • Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell’Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC and Taioli E . (2001). Cancer Epidemiol. Biomark. Prev., 10, 1239–1248.

  • International Agency for Research on Cancer (1986). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, :Tobacco Smoking. IARC: Lyon.

  • Le Marchand L, Hankin JH, Pierce LM, Sinha R, Nerurkar PV, Franke AA, Wilkens LR, Kolonel LN, Donlon T, Seifried A, Custer LJ, Lum-Jones A and Chang W . (2002). Mutat Res., 506–507, 205–214.

  • Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, Masala G, Berrino F, Panico S, Tumino R, Vineis P and Palli D . (2003). Cancer Epidemiol. Biomark. Prev., 12, 674–677.

  • Nicas M and Lomax GP . (1999). J. Occup. Environ. Med., 41, 535–544.

  • Riboli E and Lambert L . (2002). IARC Science Publication No. 156. International Agency for Research on Cancer, Lyon.

  • Taioli E . (1999). Cancer Epidemiol. Biomark. Prev., 8, 727–728.

  • Vineis P, Alavanja M . and Garte S . (2004). Int J Cancer, 108, 2–7.

  • Vineis P, Malats N, Lang M, d’Errico A, Caporaso N, Cuzick J and Boffetta P . (1999). IARC Scientific Publication No. 148. International Agency for Research on Cancer, Lyon.

  • Vineis P and McMichael AJ. . (1996). Cancer Causes Control, 7, 479–486.

  • Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Le Marchand L, Ohshima S, Pastorelli R, Rannug A, Romkes M, Schoket B, Shields P, Strange RC, Stucker I, Sugimura H, Garte S, Gaspari L and Taioli E . (2003). Int. J. Cancer, 104, 650–657.

  • Vogelstein B and Kinzler KW . (1998). The Genetic Basis of Human Cancer. McGraw-Hill: New York.

    Google Scholar 

  • Watson MA, Stewart RK, Smith GB, Massey TE and Bell DA . (1998). Carcinogenesis, 19, 275–280.

  • Weber WW . (1999). Mol. Diagn., 4, 299–307.

  • Ye Z and Parry JM . (2002). Med. Sci. Monit., 8, CR558–CR565.

Download references

Acknowledgements

This paper has been made possible by a grant of the European Union (QLK4-1999-00927) and a grant from the Compagnia di San Paolo (Torino) and from the Associazione Italiana Per La Ricerca Sul Cancro. I am grateful to Seymour Garte, Emanuela Taioli and Giuseppe Matullo for comments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paolo Vineis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vineis, P. Individual susceptibility to carcinogens. Oncogene 23, 6477–6483 (2004). https://doi.org/10.1038/sj.onc.1207897

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207897

Keywords

Search

Quick links